Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the ...

There’s currently no reliable screening test for ovarian cancer, meaning that most cases are caught at an advanced stage, ...

Ovarian cancer spreads fast by recruiting the body’s own protective cells to clear the way—and that secret alliance may finally be its undoing.

Ovarian cancer standard of care has not advanced in over 30 years, but a new DNA-based immunotherapy could be a gamechanger, showing major survival gains in clinical trials.

Treatment with relacorilant plus Abraxane (nab-paclitaxel) may offer a broader option for patients with platinum-resistant ...

Differentiating palliative care from hospice is crucial; palliative care focuses on holistic treatment, while hospice emphasizes comfort in end-of-life stages. Stick your toes in the ocean. Feed the ...

Gemogenovatucel-T is a DNA-engineered, triple-function immunotherapy that utilizes a patient's autologous tumor cells as a source for the complete matrix of tumor-related clonal signals. Its mechanism ...

A charity has warned that changes to a flight route could result in same-day return travel being impossible for some cancer ...

The study added to a large existing volume of evidence that has consistently shown a risk-reducing effect of OBS on ovarian cancer, said Karen H. Lu, MD, of Moffitt Cancer Center in Tampa, Florida and ...

PhotonPharma Inc., a biopharmaceutical company pioneering personalized cancer immunotherapies, today announced that patient recruitment has opened for its Phase 1 clinical trial evaluating Innocell™ ...

A Nanaimo gynecologist is advocating for Island general surgery departments to roll out a procedure after a new report shows a high success rate in reducing the risk of ovarian cancer.

Strategic Restructuring Eliminates Expenses Not Essential to the Phase 3 StudyKhursheed Anwer, Ph.D., Executive Vice President and Chief ...